REPONEX PHARMACEUTICALS A/S
Credit rating
Company information
About REPONEX PHARMACEUTICALS A/S
REPONEX PHARMACEUTICALS A/S (CVR number: 30082346) is a company from HØRSHOLM. The company recorded a gross profit of 241 kDKK in 2016. The operating profit was -302 kDKK, while net earnings were -332 kDKK. The profitability of the company measured by Return on Assets (ROA) was -3.8 %, which can be considered poor and Return on Equity (ROE) was -6.3 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 65.8 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. REPONEX PHARMACEUTICALS A/S's liquidity measured by quick ratio was 8.9 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2016 | |
---|---|
Volume | |
Net sales | |
Gross profit | 241.00 |
EBIT | - 302.00 |
Net earnings | - 332.00 |
Shareholders equity total | 5 229.00 |
Balance sheet total (assets) | 7 942.00 |
Net debt | -2 658.00 |
Profitability | |
EBIT-% | |
ROA | -3.8 % |
ROE | -6.3 % |
ROI | -4.0 % |
Economic value added (EVA) | - 238.72 |
Solvency | |
Equity ratio | 65.8 % |
Gearing | |
Relative net indebtedness % | |
Liquidity | |
Quick ratio | 8.9 |
Current ratio | 10.2 |
Cash and cash equivalents | 2 658.00 |
Capital use efficiency | |
Trade debtors turnover (days) | |
Net working capital % | |
Credit risk | |
Credit rating | BB |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.